Search Within

Patrick Glyn Morris

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (21)
  2. Meeting Abstract (15)
Groups
  1. Epidemiology and Biostatistics (36)
  2. Biostatistics Service (33)
  3. Department of Medicine (30)
  4. Solid Tumor Oncology Division (30)
  5. Survivorship Research (30)
  6. Breast Medicine Service (29)

More Groups

People
  1. Clifford Hudis (28)
  2. Sujata Patil (27)
  3. Larry Norton (16)
  4. Heather Mcarthur (14)
  5. Chau Dang (11)
  6. Alyson Merced (8)

More People

Years
  1. 2018 (1)
  2. 2016 (2)
  3. 2014 (1)
  4. 2013 (7)
  5. 2012 (8)
  6. 2011 (6)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Cancer Research (5)
  3. Cancer (4)
  4. Clinical Breast Cancer (4)
  5. Breast Journal (1)
  6. Cancer Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (6)
  3. Elsevier Inc. (6)
  4. Wiley Blackwell (6)
  5. Taylor & Francis Group (2)
  6. Cell Press (1)

More Publishers

Results (36)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results
    Journal Article

    Morris, P. G.; Van Poznak, C.; Modi, S.; Mak, A. F.; Patil, S.; Larson, S.; Hudis, C. A.; Divgi, C.; Grewal, R. K.
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer
    Journal Article

    Morris, P. G.; Lynch, C.; Feeney, J. N.; Patil, S.; Howard, J.; Larson, S. M.; Dickler, M.; Hudis, C. A.; Jochelson, M.; Mcarthur, H. L.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea
    Journal Article

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Sugarman, S.; Morris, P.; Abbruzzi, A.; Chen, C.; Steingart, R.; Patil, S.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H.; Rugo, H.; Nulsen, B.; Traina, T.; Patil, S.; Zhou, Q.; Steingart, R.; Dang, C.; Park, J.; Moasser, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Bone scintigraphy (BS) may no longer be relevant in the era of integrated PET/CT for women undergoing evaluation for suspected metastatic breast cancer (MBC)
    Meeting Abstract

    Mcarthur, H. L.; Lynch, C.; Morris, P.; Larson, S.; Grabski, K.; Howard, J.; Patil, S.; Hudis, C. A.; Dickler, M. N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Editorial: Adjuvant anthracyclines and taxanes: Quantifying the costs of therapeutic advances in breast cancer
    Journal Article

    Morris, P. G.; Bach, P. B.
    Onkologie (2009)

    Fulltext@MSK | Save